论文部分内容阅读
最近,降压药的研究取得了令人瞩目的进步。目前,高血压病是能用药物完全控制的慢性疾病之一。特别是α-受体阻断药,大部分β-受体阻断药,α、β-受体阻断药,血管紧张素酶(ACE)抑制剂等,5年来相继投入使用。另外,加上中枢性交感神经作用药和血管扩张药的新产品、C_a~(++)拮抗药也作降压药广泛应用。由于效果显著,从而确立了其作为降压药的地位。现在,临床使用的降压药,已包括控制机体循环调节有关特异因子的药物,还开发了新的β-受体阻断剂和C_a~(++)拮抗剂等各种
Recently, the research on antihypertensive drugs has made remarkable progress. Hypertension is currently one of the chronic diseases that can be completely controlled with medication. In particular, α-receptor blockers, most β-blockers, α, β-blockers and angiotensin (ACE) inhibitors have been put into use for 5 years. In addition, coupled with the central sympathetic and vasodilator drugs central new products, C_a ~ (++) antagonist is also widely used as antihypertensive drugs. As a result of significant, thus establishing its position as antihypertensive drugs. Now, the clinical use of antihypertensive drugs, including the control of the body to regulate specific factors related to the cycle of drugs, also developed a new β-blockers and C_a ~ (++) antagonist and other